FDA-RFP-2020-1229392 Impact of Anatomical Location on Device-Related Immune Responses. Utilization Data
Closed Solicitation Posted
- Solicitation number
- FDA-RFP-2020-1229392
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621111 Offices of Physicians (except Mental Health Specialists)
- Place of performance
- Beltsville MD 20705 USA
Notice details come from SAM.gov. Updated .
Notice text
The objective of this acquisition is to address how differences between metal-containing devices and contacting tissues (e.g., mucosal-contacting, endothelial-contacting, etc.) impact the innate and adaptive immune responses. This effort will utilize in vivo models to assess whether innate and adaptive immune responses vary across anatomical locations and with device type/characteristics. With respect to metal-containing implants, the results of this effort could:
- enable better prediction of tissue-specific adverse reactions post implantation, and
- provide knowledge needed to potentially mitigate tissue-specific adverse reactions post implantation. See attached RFQ and respond as required.
Files
| File | Type | Posted |
|---|---|---|
| Amendment 2 Responses to Questions.docx | DOCX document | |
| Amendment 1.docx | DOCX document | |
| Attachment i NDA.pdf | ||
| FDA-RFP-2020-1229392 Impact of Anatomical Location on Device-Related Immune Responses.doc | DOC document | |
| Attachment ii FDA 1335 Personnel Security Clearance Requirements.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Impact of Anatomical Location on Device-Related Immune Responses | Solicitation | |
| Clinical Pharmacology Subscription | Award Notice | |
| Clinical Pharmacology Subscription | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity